PMID- 25966070
OWN - NLM
STAT- MEDLINE
DCOM- 20160421
LR  - 20221207
IS  - 1676-5680 (Electronic)
IS  - 1676-5680 (Linking)
VI  - 14
IP  - 2
DP  - 2015 Apr 10
TI  - Promotive effect of comprehensive management on achieving blood glucose control 
      in senile type 2 diabetics.
PG  - 3062-70
LID - 10.4238/2015.April.10.16 [doi]
AB  - The aim of this study was to evaluate the control of blood glucose and 
      glycosylated hemoglobin A1c (HbA1c) and its influencing factors, in elderly type 
      2 diabetic mellitus (T2DM) patients undergoing comprehensive management. After 
      years of comprehensive prevention of and control measures for diabetes, elderly 
      T2DM patients who were receiving long-term health care were comprehensively 
      evaluated through an annual physical examination. In addition to routine health 
      examination, the patients were required to undergo HbA1c measurement. Among 688 
      patients, 652 were men and 36 were women, with a mean age of 78.2 +/- 9.1 years. 
      The average HbA1c was 6.6 +/- 0.9%. A total of 50.6% of the patients had HbA1c 
      <6.5%, whereas 76.3% had HbA1c <7.0%. Among all patients, 77.1, 46.4, 66.1, 67.8, 
      36.3, and 57.4% achieved the target total cholesterol, low-density lipoprotein 
      (LDL), high-density lipoprotein (HDL), triglyceride (TG), blood pressure, and 
      body mass index (BMI) levels, respectively. The duration of disease and type of 
      treatment, as well as the LDL, HDL, TG, BMI, and blood pressure levels, were 
      significantly associated with HbA1c control. No patient was admitted because of 
      ketoacidosis or hyperosmolar nonketotic diabetic coma in 10 years. Approximately 
      half of the T2DM patients achieved the target HbA1c level. The more effective 
      blood glucose control observed in our study compared with previous studies can be 
      attributed to the effective monitoring of medical conditions and comprehensive 
      management of patients.
FAU - Yan, S-T
AU  - Yan ST
AD  - Department of Geriatric Endocrinology, PLA General Hospital, Beijing, China.
FAU - Li, C-X
AU  - Li CX
AD  - Department of Geriatric Endocrinology, PLA General Hospital, Beijing, China.
FAU - Li, C-L
AU  - Li CL
AD  - Department of Geriatric Endocrinology, PLA General Hospital, Beijing, China.
FAU - Li, J
AU  - Li J
AD  - Department of Geriatric Endocrinology, PLA General Hospital, Beijing, China.
FAU - Shao, Y-H
AU  - Shao YH
AD  - Department of Geriatric Endocrinology, PLA General Hospital, Beijing, China.
FAU - Liu, Y
AU  - Liu Y
AD  - Department of Geriatric Endocrinology, PLA General Hospital, Beijing, China.
FAU - Zhong, W-W
AU  - Zhong WW
AD  - Department of Geriatric Endocrinology, PLA General Hospital, Beijing, China.
FAU - Fang, F-S
AU  - Fang FS
AD  - Department of Geriatric Endocrinology, PLA General Hospital, Beijing, China.
FAU - Sun, B-R
AU  - Sun BR
AD  - Department of Geriatric Endocrinology, PLA General Hospital, Beijing, China.
FAU - Tian, H
AU  - Tian H
AD  - Department of Geriatric Endocrinology, PLA General Hospital, Beijing, China 
      stthcn@126.com.
LA  - eng
PT  - Journal Article
DEP - 20150410
PL  - Brazil
TA  - Genet Mol Res
JT  - Genetics and molecular research : GMR
JID - 101169387
RN  - 0 (Blood Glucose)
RN  - 0 (Glycated Hemoglobin A)
RN  - 0 (hemoglobin A1c protein, human)
RN  - 97C5T2UQ7J (Cholesterol)
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - Alzheimer Disease/*blood/*therapy
MH  - Blood Glucose/*metabolism
MH  - Cholesterol/blood
MH  - Diabetes Mellitus, Type 2/*blood/psychology/*therapy
MH  - Female
MH  - Glycated Hemoglobin/metabolism
MH  - Humans
MH  - Male
EDAT- 2015/05/13 06:00
MHDA- 2016/04/22 06:00
CRDT- 2015/05/13 06:00
PHST- 2015/05/13 06:00 [entrez]
PHST- 2015/05/13 06:00 [pubmed]
PHST- 2016/04/22 06:00 [medline]
AID - gmr4696 [pii]
AID - 10.4238/2015.April.10.16 [doi]
PST - epublish
SO  - Genet Mol Res. 2015 Apr 10;14(2):3062-70. doi: 10.4238/2015.April.10.16.